|
USP45 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.922400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.040570E-03 |
| Normal-vs-Stage2 |
6.630800E-01 |
| Normal-vs-Stage3 |
1.027010E-01 |
| Normal-vs-Stage4 |
6.549000E-01 |
| Stage1-vs-Stage2 |
1.236780E-01 |
| Stage1-vs-Stage3 |
5.743000E-01 |
| Stage1-vs-Stage4 |
9.735900E-02 |
| Stage2-vs-Stage3 |
3.880200E-01 |
| Stage2-vs-Stage4 |
4.926600E-01 |
| Stage3-vs-Stage4 |
1.657820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.439200E-03 |
| Normal-vs-AfricanAmerican |
5.252300E-02 |
| Normal-vs-Asian |
1.386770E-01 |
| Caucasian-vs-AfricanAmerican |
5.509000E-01 |
| Caucasian-vs-Asian |
9.205400E-01 |
| AfricanAmerican-vs-Asian |
7.830000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.743210E-03 |
| Normal-vs-Female |
8.081600E-02 |
| Male-vs-Female |
2.881600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.386300E-02 |
| Normal-vs-Extreme_Weight |
7.35490000014494E-07 |
| Normal-vs-Obese |
2.772200E-02 |
| Normal-vs-Extreme_Obese |
4.139200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.902000E-02 |
| Normal_Weight-vs-Obese |
8.954200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.459600E-01 |
| Extreme_Weight-vs-Obese |
2.793800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.732500E-02 |
| Obese-vs-Extreme_Obese |
5.865400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.293600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.388000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.595560E-03 |
| Normal-vs-Age(81-100Yrs) |
1.415790E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.354600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.939820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.844700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.141250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.008300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.383000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.110300E-02 |
| Normal-VS-Type2 PRCC |
5.298400E-03 |
| Normal-VS-KIRP CIMP |
7.650000E-02 |
| Normal-VS-Unclassified PRCC |
1.104220E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.203200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.263000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.868000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.806800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.359000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.137200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.427300E-04 |
| Normal-vs-N1 |
9.396800E-01 |
| Normal-vs-N2 |
8.447900E-04 |
| N0-vs-N1 |
4.152100E-02 |
| N0-vs-N2 |
1.022230E-01 |
| N1-vs-N2 |
6.092300E-02 |
|
|
